In 1910, Professor Ernst Fuchs, an Austrian ophthalmologist, published an article describing 13 patients with Fuchs’ dystrophy, a condition in the cornea that subsequently bears his name. The patients ...

Design Therapeutics is set to present significant safety findings from its Phase 1 trial of DT-168, highlighting progress in their clinical development for treating Fuchs endothelial corneal dystrophy ...

Cloudy vision can develop due to underlying health conditions such as cataracts, macular degeneration, or inflammatory eye condtions. Knowing the signs of cloudy vision and the conditions that can ...